Long-lasting effect of belantamab mafodotin in heavily pretreated multiple myeloma

Gil-Sierra, MD; Briceno-Casado, MD; Julia-Luna, FJ; Martinez-Moya, MD

Gil-Sierra, MD (通讯作者)，Calle Playa Bolonia 10, Cadiz 11406, Spain.

INDIAN JOURNAL OF PHARMACOLOGY, 2022; 54 (5): 373

Abstract

Belantamab mafodotin (BLMF) is an interesting therapeutic alternative for multiple myeloma (MM) patients pretreated with immunomodulatory drugs, prote......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索